tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market
CYTK
Cytokinetics
RESEARCH TOOLSreports

Cytokinetics (CYTK) Stock News & Sentiment

1,243 Followers
MYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK
Premium
Ratings
MYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK
8h ago
CYTK
Cytokinetics Earnings Call Marks High-Stakes Launch Phase
Premium
Company Announcements
Cytokinetics Earnings Call Marks High-Stakes Launch Phase
25d ago
CYTK
FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline
Premium
Company Announcements
FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline
1M ago
CYTK
Cytokinetics: Strong Myqorzo Launch, Expanding Market Access, and Upcoming HCM Milestones Underpin Buy Rating
Premium
Ratings
Cytokinetics: Strong Myqorzo Launch, Expanding Market Access, and Upcoming HCM Milestones Underpin Buy Rating
1M ago
CYTK
Cytokinetics (CYTK) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Cytokinetics (CYTK) Q4 Earnings Cheat Sheet
1M ago
CYTK
MYQORZO: EC Approval, Differentiated Label, and Global HCM Expansion Support Buy on CYTK
Premium
Ratings
MYQORZO: EC Approval, Differentiated Label, and Global HCM Expansion Support Buy on CYTK
1M ago
CYTK
Cytokinetics Wins European Approval for MYQORZO in HCM
Premium
Company Announcements
Cytokinetics Wins European Approval for MYQORZO in HCM
1M ago
8K
CYTK
More CYTK News >

CYTK News on the Web

Why Is Cytokinetics (CYTK) Down 0.8% Since Last Earnings Report?
Zacks
Bearish
Sarissa Capital Management LP Reduces Stake in Ironwood Pharmaceuticals Inc.
GuruFocus News
Neutral
Bank of America Securities Keeps Their Hold Rating on Cytokinetics (CYTK)
TipRanks News
Bearish
Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Aardvark Therapeutics, Inc. (AARD) and Incyte (INCY)
TipRanks News
Bullish
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
The Motley Fool
Neutral
Cytokinetics Insiders Make Bold Moves With Fresh Wave of Stock Sales
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Perspective Therapeutics (CATX)
TipRanks News
Bullish
Cytokinetics price target raised to $100 from $84 at Mizuho
TipRanks News
Bullish

News Score - Last 7 Days

Negative
CYTK
Sector Average
Media Buzz
This Week4 articles
Weekly Average6 articles
News Sentiment
This Week33%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CYTK’s Media Buzz Sentiment?
4 articles about CYTK were published this week. In an average week, 6 articles are published.
    What is CYTK’s weekly average amount of articles?
    In an average week, 6 articles about CYTK are published.
      What is CYTK’s News Sentiment?
      33% of articles about CYTK were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        WXIBFWuxi Biologics (Cayman)
        KODKodiak Sciences
        SHTDYSinopharm Group Co
        640China Resources Pharmaceutical Group Ltd.
        RZLTRezolute
        Showing the stocks with the most bullish news sentiment over the past week